亚洲G6PD-Mahidol网织红细胞支持间日疟原虫正常发育
该实验研究探讨东南亚常见的G6PD-Mahidol G487A变异是否阻碍间日疟原虫感染。结果显示,间日疟原虫侵犯的CD71+未成熟网织红细胞在半合子突变者中酶活性正常,允许疟原虫正常生长、发育并达到高密度。
要点
- G6PD-Mahidol G487A半合子突变者的CD71+网织红细胞酶活性正常。
- 间日疟原虫在严重G6PD缺乏样本中可正常生长、发育并达高密度。
- G6PD-Mahidol变异不构成间日疟原虫感染的屏障。
核心结论
- G6PD-Mahidol G487A变异不阻碍间日疟原虫感染,其靶细胞CD71+网织红细胞酶活性正常,支持疟原虫正常发育。
研究设计与样本
- 实验研究,采用G6PD-Mahidol G487A半合子突变样本,检测CD71+网织红细胞的酶活性及间日疟原虫生长情况。
主要发现
- 在G6PD-Mahidol G487A半合子突变者中,CD71+未成熟网织红细胞酶活性正常。
- 严重G6PD缺乏样本中间日疟原虫可正常生长、发育并达到高 parasite density。
临床怎么用
- 临床不应假设G6PD-Mahidol变异对间日疟原虫感染具有保护作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymatic disorder in humans and appears to be protective against falciparum severe malaria. Controversially, it is also thought that Plasmodium vivax has driven the recent selection of G6PD alleles. We use an experimental approach to determine whether G6PD-MahidolG487A variant, a widespread cause of severe G6PD deficiency in Southeast Asia, provides a barrier against vivax malaria. Our results show that the immature reticulocytes (CD71+) targeted by P. vivax invasion are enzymatically normal, even in hemizygous G6PD-Mahidol G487A mutants; thus, allowing the normal growth, development, and high parasite density in severely deficient samples.
引用
- Bancone G, Malleret B, Suwanarusk R, et al. Asian G6PD-Mahidol Reticulocytes Sustain Normal Plasmodium Vivax Development. J Infect Dis. 2017. PMID: 28591790. doi:10.1093/infdis/jix278
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。